Gagnon Securities LLC Soma Logic, Inc. Transaction History

Gagnon Securities LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.76 - $2.83 $3,379 - $5,433	-1,920 Reduced 0.24%	805,224 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$1.99 - $2.45 $3,595 - $4,427	1,807 Added 0.22%	807,144 $1.93 Million
Q2 2023 Aug 08, 2023	SELL	$2.1 - $3.36 $56,204 - $89,927	-26,764 Reduced 3.22%	805,337 $1.86 Million
Q1 2023 Apr 10, 2023	SELL	$2.13 - $3.6 $89,649 - $151,520	-42,089 Reduced 4.81%	832,101 $2.12 Million
Q4 2022 Feb 07, 2023	SELL	$2.05 - $3.47 $1.35 Million - $2.28 Million	-656,282 Reduced 42.88%	874,190 $2.19 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $5.47 $375,630 - $3.26 Million	596,239 Added 63.82%	1,530,472 $4.44 Million
Q2 2022 Aug 01, 2022	BUY	$4.27 - $8.26 $122,015 - $236,029	28,575 Added 3.16%	934,233 $4.22 Million
Q1 2022 May 09, 2022	BUY	$7.07 - $11.62 $516 - $848	73 Added 0.01%	905,658 $7.26 Million
Q4 2021 Feb 08, 2022	SELL	$10.49 - $14.28 $207,261 - $282,144	-19,758 Reduced 2.14%	905,585 $10.5 Million
Q3 2021 Nov 12, 2021	BUY	$9.94 - $12.77 $9.2 Million - $11.8 Million	925,343 New	925,343 $11.5 Million

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gagnon Securities LLC with notifications on news.